Multidrug resistance-1 (MDR-1) in autoimmune disorders III: Increased P-glycoprotein activity inlymphocytes from immune thrombocytopenic purpura patients

Multidrug resistance in cancer: role of ATP–dependent transporters

2002 • 5,195 citations

Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]

1996 • 1,438 citations

Immune Thrombocytopenic Purpura

2002 • 1,324 citations

Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]

1996 • 1,155 citations

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

1989 • 565 citations

Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein.

1987 • 538 citations

Multidrug resistance: molecular mechanisms and clinical relevance

1997 • 516 citations

P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil.

1991 • 388 citations

Drugs as P-glycoprotein substrates, inhibitors, and inducers

2002 • 364 citations

P-glycoproteins in pathology: The multidrug resistance gene family in humans

1990 • 173 citations

Function, evolution and structure of multidrug resistance protein (MRP)

1997 • 168 citations

Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part I: Increased P-glycoprotein activity in lymphocytes from rheumatoid arthritis patients might influence disease outcome.

2000 • 86 citations

The Role of Drug Efflux Pumps in Acute Myeloid Leukemia

2002 • 81 citations

Modulators of Multidrug Resistance: Preclinical Studies

1995 • 78 citations

Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part II: Increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control.

2000 • 51 citations

Clinical Reversal of Multidrug Resistance

1996 • 41 citations

Multidrug Resistance: Clinical Opportunities in Diagnosis and Circumvention

1994 • 31 citations

Relevance of multidrug resistance to rheumatoid arthritis: development of a new therapeutic hypothesis.

1996 • 28 citations

Evidence of post-translational regulation of P-glycoprotein associated with the expression of a distinctive multiple drug-resistant phenotype in Chinese hamster ovary cells

1993 • 27 citations

Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.

2000 • 26 citations

High P‐glycoprotein‐mediated export observed in patients with a history of idiopathic thrombocytopenic purpura

2002 • 21 citations

"Pros and Cons" on How to Measure Multidrug Resistance in Leukemias

2002 • 6 citations